Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Declines By 75.4%

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a large drop in short interest during the month of January. As of January 15th, there was short interest totaling 14,803 shares, a drop of 75.4% from the December 31st total of 60,091 shares. Based on an average daily trading volume, of 1,035,303 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are short sold. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 1,035,303 shares, the days-to-cover ratio is presently 0.0 days.

CV Sciences Stock Performance

Shares of CVSI traded down $0.00 during mid-day trading on Thursday, hitting $0.04. 135,865 shares of the company’s stock were exchanged, compared to its average volume of 475,855. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.21. CV Sciences has a 52 week low of $0.02 and a 52 week high of $0.10. The company has a 50-day simple moving average of $0.04 and a 200 day simple moving average of $0.04.

CV Sciences Company Profile

CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.